China’s drug regulator has accepted Novo Nordisk’s application to sell an oral version of its Wegovy weight-loss drug, according to a Reuters report published on August 27. The regulatory filing in the world’s second-largest pharmaceutical market marks a step for the Danish drugmaker as it chases rival Eli Lilly in the burgeoning anti-obesity sector. Regulatory … Read more
New research indicates that patients using GLP-1 drugs for weight loss or diabetes management face a higher risk of developing alopecia compared to those taking other classes of diabetes medications. While the overall incidence remains low—estimated between 3 and 9 per 1,000 people annually—studies published in The BMJ and the Journal of the American Academy … Read more
Public health authorities are currently scrambling to secure medical countermeasures for an outbreak of the Bundibugyo strain of the Ebola virus in the Democratic Republic of Congo. With 2,473 confirmed cases and 999 deaths reported by the government, the lack of approved vaccines or treatments for this specific strain—which carries a fatality rate of up … Read more
New Cardiovascular Guidelines Expand Statin Eligibility to Millions Updated medical guidelines issued by the American Heart Association and the American College of Cardiology are set to expand the use of cholesterol-lowering statin drugs to an additional 21.5 million Americans. According to research published in JAMA, these recommendations move the assessment of cardiovascular risk from a … Read more
New medical research reveals a dual frontier in human health: microplastics have been identified as a potential cardiovascular risk factor, while an investigational vaccine is showing promise in preventing pancreatic cancer among high-risk individuals. Both developments suggest a shift toward proactive, biology-based interventions for chronic disease. Microplastics and Cardiovascular Risk A study published in the … Read more
Brazil’s Strategic Response to U.S. Tariffs Includes Patent Suspensions and WTO Revival Brazil is preparing to retaliate against U.S. tariffs by targeting intellectual property rights and audiovisual sector interests, according to three sources familiar with the discussions. The measures, which could include suspending pharmaceutical and agricultural seed patents, aim to pressure Washington while avoiding consumer … Read more
Global childhood vaccination rates rose slightly in 2025, with 90% of infants receiving at least one dose of the DTP vaccine, according to data from the World Health Organization (WHO) and UNICEF. Despite this, 13.5 million children remain “zero-dose,” leaving millions vulnerable to preventable diseases amid funding cuts and active conflicts. The Gap Between First … Read more
The U.S. Food and Drug Administration (FDA) has proposed a new regulatory framework designed to modernize how distributed pharmaceutical manufacturing sites register with the agency. Under the proposal, companies utilizing a “hub-and-spoke” manufacturing model—where a central location oversees multiple production units—would be permitted to register as a single establishment. The rule also mandates tighter reporting … Read more
The U.S. Food and Drug Administration (FDA) has officially accepted for review Sandoz’s applications for two generic versions of tirzepatide, the active ingredient in Eli Lilly’s popular weight-loss and diabetes treatments. This regulatory step marks a significant move toward potential market competition for Mounjaro and Zepbound ahead of the expiration of Eli Lilly’s U.S. patents … Read more
Roche has launched its Axelios gene sequencer, a new platform designed to perform large-scale DNA and RNA analysis, marking the company’s attempt to compete with industry leader Illumina. Roche aims to sell about 100 machines within the first year, targeting academic and research institutions to build a foundation for long-term growth in the $7.3 billion … Read more